INCRETIN-BASED THERAPIES IN OBESITY-RELATED HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): A SYSTEMATIC REVIEW OF EMERGING CARDIOMETABOLIC DISEASE MODIFICATION BEYOND GLYCEMIC CONTRO